Invitation to presentation in connection with EQL Pharma's year-end report, fourth quarter, 2023/24

EQL Pharma AB (publ) will publish its year-end report for the fourth quarter, 2023/24, on Tuesday, May 14^th, after stock markets closing.

At 10.00 (CET) 15^th May, the company will give a presentation via video conference. The presentation is aimed at shareholders and potential shareholders. CEO and President Axel Schörling presents and comments on the year-end report. After the presentation, there is an opportunity to ask questions for those who participate.

Use the following link to access the virtual meeting: https://tinyurl.com/ysf2a9te

Date and time

May 15^th, 2024, at 10.00 (CET) the presentation starts. Time required for presentation and subsequent question time is estimated at a maximum 1 hour.

Make sure you are able to attend the video conference by logging in shortly before the start of the conference.